key: cord-0954728-9db9dpvd authors: Vaseghi, G.; Mansourian, M.; Karimi, R.; Heshmat-Ghahdarijani, k.; Rouhi, P.; Shariati, M.; Haghjoo Javanmard, S. title: Inflammatory markers in Covid-19 Patients: a systematic review and meta-analysis. date: 2020-05-02 journal: nan DOI: 10.1101/2020.04.29.20084863 sha: 778d719ea8d1b604972284750890cb05909afb5a doc_id: 954728 cord_uid: 9db9dpvd Introduction Diagnosis of COVID-19 is based on clinical manifestation, history of exposure, positive findings on chest CT and laboratory tests. It has been shown that inflammation plays a role in pathogenesis of COVID-19. Method We used the necessary transformations to convert the median and IQR to mean and SD Random-effect model using Der Simonian, and Laird methods was used if heterogeneity between studies was significant, the homogeneity among studies was assessed with I2 Statistic, values above 50%, and for the chi-square test, P-values <0.1 was supposed statistically significant Results Twelve studies were included in the analysis that all of which were conducted in China in the year 2020. The result of combining 12 articles with 772 participants showed that the pooled estimate of the mean of lymphocyte with 95% CI was (Mean: 1.01; 95% CI (0.76-1.26); p-value<0.001). About WBC the pooled result of 9 studies with 402 participants was (Mean: 5.11; 95% CI (3.90-6.32); p-value<0.001) Also the pooled mean estimate of 9 studies with 513 patients for the ratio of Neutrophil/lymphocyte was (Mean: 3.62; 95% CI (1.48-5.77); p-value=0.001). The pooled mean from the combination of 7 studies with 521 patients on CRP was (Mean: 28.75; 95% CI (8.04-49.46). Conclusion Inflammatory Markers increase in patients with Covid-19, which can be a good indicator to find patients. Diagnosis of COVID-19 is based on clinical manifestation, history of exposure, positive findings on chest CT and laboratory tests. It has been shown that inflammation plays a role in pathogenesis of COVID-19. We used the necessary transformations to convert the median and IQR to mean and SD Random-effect model using Der Simonian, and Laird methods was used if heterogeneity between studies was significant, the homogeneity among studies was assessed with I 2 Statistic, values above 50%, and for the chi-square test, P-values <0.1 was supposed statistically significant Twelve studies were included in the analysis that all of which were conducted in China in the year 2020. The result of combining 12 articles with 772 participants showed that the pooled estimate of the mean of lymphocyte with 95% CI was (Mean: 1.01; 95% CI (0.76-1.26); p-value<0.001). About WBC the pooled result of 9 studies with 402 participants was (Mean: 5.11; 95% CI (3.90-6.32); p-value<0.001) Also the pooled mean estimate of 9 studies with 513 patients for the ratio of Neutrophil/lymphocyte was (Mean: 3.62; 95% CI (1.48-5.77); p-value=0.001). The pooled mean from the combination of 7 studies with 521 patients on CRP was (Mean: 28.75; 95% CI (8.04-49.46). All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Diagnosis of COVID-19 is based on clinical manifestation, history of exposure, positive findings on chest CT and laboratory tests (5) . It has been shown that inflammation plays a role in pathogenesis of COVID-19 (6) . In these patients release of pro-inflammatory cytokines followed by inflammasome activation produce lung injury (7) . Systemic inflammation changes the features of circulating blood cells have been suggested to be biomarkers for assessment of inflammatory activity. Neutrophilia with lymphopenia is a response of the innate immune system to systemic inflammation. The neutrophil-to-lymphocyte ratio (NLR) is another inflammatory marker, which is the proportion of absolute neutrophil count to lymphocytes on routine All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 2, 2020. . https://doi.org/10.1101/2020.04.29.20084863 doi: medRxiv preprint complete blood count (CBC) tests. An elevated NLR is associated with the prognosis of systemic inflammatory diseases, especially infectious diseases (8) . CRP as the most representative of acute phase reactants, is elevated in many respiratory viral infections (9) . CRP testing is used at the forefront for evaluation of infection and is important for COVID-19 management (10). In this meta-analysis, we decided to evaluate the White blood cell and lymphocyte count, NLR and CRP titer in COVID-19 to use these findings in the diagnosis of the COVID-19 more rapidly and accurately. We used Systematic Reviews and Meta-Analyses Statement for Scoping Reviews" (PRISMA-ScR) (11 Infection" OR "2019 nCoV Infection" OR "2019 nCoV Infection" OR "2019-nCoV Infections" OR Betacoronavirus* OR "Novel Coronavirus Pneumonia" OR "2019 novel coronavirus" OR "coronavirus disease 2019" OR "nCoV" OR covid* OR "bat coronavirus")). We included all case control, editorial and epidemiological studies. Titles and abstracts of all searches were screened independently by two All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 2, 2020. . https://doi.org/10.1101/2020.04.29.20084863 doi: medRxiv preprint investigators. Articles deemed potentially eligible were retrieved for full-text review. Non-English publications were translated by a native/fluent speaker. Two measures of association were used in studies; mean (SD) and median (IQR). We used the necessary transformations to convert the median and IQR to mean and SD (12) . Therefore, the pooled estimation is reported based on mean and a corresponding 95% CI. Random-effect model using Der Simonian and Laird methods was used if heterogeneity between studies was significant, to Summary the results, otherwise a model with fixed effect was calculated (13) . The homogeneity among studies was assessed with I 2 Statistic, values above 50%, and for the chi-square test, P-values <0.1 was supposed statistically significant (14) . Publication bias was evaluated with Begg's rank correlation tests and Egger's linear regression tests (15) . If the test for Publication bias become significant, trim and fill methods were used to modify the results. All analyses were performed using STATA version 14. Figure to 75 years. Summary information of each article is presented in Table. 1, As shown in Table. 2, The result of combining 12 articles with 772 participants showed that the pooled estimate of the mean of lymphocyte with 95% CI was (Mean:1.01; 95% CI (0.76-1.26); p-value<0.001, Figure. 2). About WBC the pooled result of 9 studies with 402 participants was (Mean: 5.11; 95% CI (3.90-6.32); p-value<0.001) (the forest plot is presented in Figure. 3). Also the pooled mean estimate of 9 studies with 513 patients for the ratio of All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 2, 2020. Several studies have suggested that increased amounts of cytokines in serum are associated with pulmonary damage in SARS and MERS-CoV infection (16,17). In this meta-analysis, we studied the inflammatory markers of CBC and lymphocyte upset in patients with COVID-19. We included all epidemiological and case report studies. The patients age was between 40 to 75 years. The blood level of WBC was normal with reduced amount of lymphocyte, as expected (18) . In terms of laboratory tests, we noted that most of infected patients presented lymphopenia and low counts of CD3+ cells and CD4+ cells have been observed in COVID-19 cases (19) . NLR is used as a marker of subclinical inflammation, especially in severe pneumonia (20) . Here we showed that the pool NLR of COVID-19 is 3.62 which is upper than physiological range. An increase of the NLR is common among patients with COVID-19, and especially in the severe cases, COVID-19 damages lymphocytes and the immune system. It has been suggested that NLR is the most significant factor affecting the severe illness incidence, and it has significant predictive value (19) . All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Based on the previous studies, Patients with 2019-nCoV pneumonia with higher NLR and age would face a worse outcome which helps their risk stratification. If there are large-scale cases, the risk stratification and management will help alleviate the shortage of medical resources and reduce the mortality of critical patients. In conclusion, in this study, we found that patients with COVID-19 have higher CRP and NLR but low lymphocyte and normal WBC, which can help in diagnosis of these patients. The authors of this article declare that they have no conflict of interests. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 2, 2020. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which this version posted May 2, 2020. . https://doi.org/10.1101/2020.04.29.20084863 doi: medRxiv preprint Outbreak of pneumonia of unknown etiology in Wuhan , China : The mystery and the miracle WHO Director-General's remarks at the media briefing on 2019-nCoV on Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Prognostic Significance of Neutrophilto-Lymphocyte Ratio in Patients with Sepsis : A Prospective Observational Study C-reactive protein and respiratory viral infection Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation Estimating the sample mean and standard deviation from the sample size , median , range and / or interquartile range Measuring inconsistency in meta-analyses A basic introduction to fixed-effect and random-effects models for meta-analysis Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile Clinical and immunologic features in severe and moderate forms of Coronavirus Disease Dysregulation of immune response in patients with COVID-19 in Wuhan Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multicenter study in Wenzhou city Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci Original Article Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study Authors would like to thank all health care workers who fight COVID-19. All rights reserved. No reuse allowed without permission.was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which this version posted May 2, 2020. . https://doi.org/10.1101/2020.04.29.20084863 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which this version posted May 2, 2020. All rights reserved. No reuse allowed without permission.was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which this version posted May 2, 2020. . https://doi.org/10.1101/2020.04.29.20084863 doi: medRxiv preprint